HLTH 2023
-
Can Psychedelic-Assisted Therapy Be Used for Prevention?
Psychedelic-assisted therapy is currently used to treat severe mental health conditions. But there is evidence it could help with prevention as well, and more research needs to be done on this, said Sherry Rais, CEO and co-founder of Enthea.
-
Artificial Intelligence, Consumer / Employer, Health Tech, Payers, Startups
11 HLTH Announcements You Don’t Want to Miss
This year’s HLTH conference brought a bevy of news announcements — from partnerships to new product features to acquisitions and more. In this list, MedCity News compiled short summaries for 11 of the conference’s most notable announcements.
-
Jorie Healthcare CEO Shares Why Automation is Critical to Revenue Cycle Management
The revenue cycle management business is using AI tools to automate cumbersome tasks to help hospitals operate more efficiently. It’s beginning to attract the attention of major healthcare organizations.
-
How Nemours Children’s Is Working to Solve the ‘Horrendous’ Youth Mental Health Crisis
If you could only do one thing to improve the health of children in the U.S., it would have to be in the behavioral health sphere, Nemours Children’s Health CEO Lawrence Moss declared at HLTH. The state of youth mental health has reached a crisis point in the U.S., and Moss’ health system is working hard to address this. Some of its efforts include embedding behavioral health into primary care and deploying behavioral health workers in schools.
-
Artificial Intelligence, Consumer / Employer, Health Tech, Hospitals, Patient Engagement, Startups
7 Hot Takes I Heard at HLTH
At HLTH 2023, I had dozens of conversations with providers, digital health investors, startup CEOs and other players in the healthcare industry. When I got home, I compiled seven refreshingly honest takes I heard from them while at the conference.
-
4 Ways Investors Think the Health Tech World Will Change in 2024
At HLTH, Bessemer investors Sofia Guerra and Steve Kraus detailed four predictions about where they think the digital health world is headed in 2024. One of these was that “services-as-software” will emerge as a new category of healthcare AI. Another was that some healthcare technology vendors will have to rethink their distribution models and rely on indirect monetization strategies.
-
Mercer Exec: Employers Are Extremely Concerned About Cost
Cancer and pharmacy services are driving up costs for employers. One Mercer exec recently laid out several recommendations for employers to manage these costs.
-
3 Questions This Healthcare Investor Finds Herself Asking Startups All The Time
At HLTH, General Catalyst Principal Candace Richardson discussed some of the questions she frequently asks startups during investment meetings. Some of these include “Do you stratify your outcomes data by different populations to ensure your model works well for everyone?” and “Is serving Medicaid populations on your roadmap?”
-
Is Medicare Advantage a Failed Experiment? Experts Debate
Enrollment in Medicare Advantage is increasing, but the program has been drawing scrutiny from the government. Can the program be saved? One expert believes Medicare Advantage is a failed experiment. Another thinks that while the program has its flaws, it shows tremendous potential.
-
Health Tech, Hospitals, Physicians
Why the AMA President Thinks Scope of Practice Expansions Are a ‘Terrible Idea’
To address the growing physician shortage, some people argue that the scope of practice should be expanded for skilled healthcare professionals like nurse practitioners and pharmacists. American Medical Association President Dr. Jesse Ehrenfeld said this is a “terrible idea.” He argued that throwing other professionals into physicians’ roles will have poor ramifications of patient safety. In his view, the industry should focus on uplifting strong interprofessional care teams.
-
Navigating Healthcare’s Data Revolution: Priorities, Opportunities, and Challenges for Health Systems
Arcadia recently partnered with HIMSS Market Insights to survey executives, IT, technology, and clinical leaders. Here’s what we found.
-
Main Street Health Rakes In $315M to Scale Value-Based Care in Rural America
Main Street Health announced the close of a $315 funding round at HLTH — some of the investors included UnitedHealthcare, Humana, Elevance, Centene and CVS. The startup, which scales value-based care in rural areas for both Medicare Advantage and original Medicare patients, also announced that it is expanding to 26 states.
-
Why One Expert Thinks the Medicare Drug Price Negotiation Program Is Here to Stay
Merith Basey, executive director of Patients For Affordable Drugs, believes the Medicare price negotiation program is here to stay, no matter who is president and no matter how many Big Pharma players file lawsuits. Her reasoning? Every other high income nation has been negotiating prices with drugmakers for years, and the program is widely popular in the U.S. among pretty much everyone who isn’t a pharma company, she said during a session at Engage at HLTH.
-
How Can LLMs Be Deployed Safely in Healthcare?
Healthcare technology experts have confidence that the industry will put the right guardrails up around LLMs as it continues to develop and deploy these AI tools, they said Sunday during a panel discussion at Engage at HLTH.
-
Two Value-Based Care Initiatives That Could Shift the Alternative Payment Model Landscape
The Centers for Medicare and Medicaid Services has announced two value-based care alternative payment models set to launch in July 2024, one focused on dementia and one on primary care.
-
HLTH Foundation’s Achievements and Ambitions for Health Equity
HLTH Foundation Executive Director Janna Guinen described its focus on promoting equity, inclusion and opportunity in healthcare on behalf of patients, healthcare professionals and health tech entrepreneurs.